Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Lactate Clearance as a Prognostic Marker in Cardiogenic Shock: A Retrospective Study from a Tertiary Cardiac Intensive Care Unit
Session:
Sessão de Comunicações Orais 04 – A bomba em falência: fronteiras hemodinâmicas e metabólicas na doença cardíaca crítica
Speaker:
Débora Da Silva Correia
Congress:
CPC 2026
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
14. Acute Cardiac Care
Subtheme:
14.4 Acute Cardiac Care – Cardiogenic Shock
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Débora da Silva Correia; Miguel Domingues; Rita Barbosa; Samuel Azevedo; Márcia Presume; Rui Gomes; Rita Carvalho; Ana Rita Bello; Jorge Ferreira; João Presume; Catarina Brízido
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Background:</strong> Cardiogenic shock (CS) carries a high in-hospital mortality exceeding 40–50%. Accurate and rapidly responding markers of perfusion are essential for early risk stratification and treatment optimization. Recent SCAI recommendations evidence supports lactate clearance (LC) as a key marker of shock trajectory, being an easily accessible bedside marker to guide management decisions, including mechanical circulatory support (MCS).</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Methods:</strong> Retrospective observational study including consecutive CS patients admitted to the cardiac intensive care unit (CICU) between 2017 and 2024. Demographic, clinical, and laboratory data, SCAI stage, and aetiology of CS were collected. Lactate measurements at admission, 6h, and 24h were obtained, and patients with any missing values were excluded. A significant LC was defined as a reduction >10%, and lactate normalization as lactate <2 mmol/L. Outcomes included mortality in the CICU, at 30 days and 1 year. Survival analysis was conducted using Cox regression and Kaplan–Meier curve, with group comparisons performed by the log-rank test<strong>.</strong></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Results:</strong> A total of 251 patients were analysed (mean age 69±16 years; 66% male). Most presented with AMI-CS (54%), and initial SCAI stages C and D accounted for 86% of admissions. MCS was required in 34%. At admission, median lactate was 3.4 [2.1–5.4] mmol/L, decreasing to 2.2 [1.4–3.8] mmol/L at 6h, and 1.6 [1.1–2.5] mmol/L at 24h. LC >10% at 6h was observed in 65% of patients, while 64% achieved lactate <2 mmol/L by 24h. Mortality reached 41% in the CICU, 45% during the index hospitalization, and 53% at one year. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">In Cox regression analysis, only lactate normalization at 24h predicted CICU mortality (HR 0.245, 95% CI 0.165–0.365; p < 0.001). Kaplan–Meier survival analysis demonstrated that both LC > 10% at 6h and lactate normalization at 24h predicted 30-day and 1-year survival, with 24h normalization demonstrating the greatest separation of survival curves. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">In patients supported with MCS, baseline lactate levels were higher (3.7 [2.2–6.2] vs. 3.2 [1.9–5.1] mmol/L), as expected. At 6h, 20 out of 85 patients without a LC >10% were receiving MCS. Of these, 50% achieved lactate normalization by 24h. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">In subgroup analysis by aetiology, the association between LC at 6h and 24h and survival at 30-day and 1-year persisted across all etiologic subgroups.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Conclusion:</strong> In this contemporary cohort of cardiogenic shock patients, early lactate clearance demonstrates a strong association with improved survival. Specifically, lactate normalization at 24 hours is highly discriminatory and independently associated with significantly reduced in-hospital and 1-year mortality across all aetiologies. These findings underscore the utility of dynamic lactate monitoring as a crucial bedside marker for risk stratification and real-time assessment of therapeutic efficacy in the management of cardiogenic shock.</span></span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site